Pfizer Reports Second-Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Needham sees mature node semiconductor strength in latest tracker
Pfizer (PFE) Tops Q2 EPS by 1c, Updates FY EPS Guidance
August 1, 2017 6:46 AM EDTPfizer (NYSE: PFE) reported Q2 EPS of $0.67, $0.01 better than the analyst estimate of $0.66. Revenue for the quarter came in at $12.9 billion versus the consensus estimate of $13.08 billion.
GUIDANCE:
Pfizer sees FY2017 EPS of $2.54-$2.60, versus the consensus of $2.55. Pfizer sees... More
